RNTECH and DNAVision announce a co-marketing agreement to offer complete solution for biomarker and target discovery
01-Feb-2006
The RNTECH/DNAVision offer associates these key components, creating a opportunity for pharmaceutical and biotechnology industries to access discovery and development expertise in oncology for biomarker and drugable target discovery and development.
Most read news
Topics
Organizations
DNAVISION
RNTech
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.